Chronic Hepatitis C

This is Hepatitis C that lasts for six months or longer. If left untreated, it can damage your liver over time and potentially lead to liver scarring called cirrhosis.

Condition

What people with Chronic Hepatitis C report

Every report comes from a Lived member, sent anonymously.

Have you tried Ribavirin for Chronic Hepatitis C?

NameHow it went

About Chronic Hepatitis C

What It Is

Chronic hepatitis C is a long-lasting infection of the liver with the hepatitis C virus (HCV). The virus causes ongoing inflammation, and over many years that inflammation can scar the liver. Heavy scarring, called cirrhosis, can lead to liver failure and raises the risk of liver cancer. Some people clear the virus on their own in the first months after infection, but most do not, and the infection becomes chronic. Chronic hepatitis C usually causes few or no symptoms until the liver is already damaged, which can be decades after infection. Many people feel well and do not know they have it, which is why testing matters. Today's antiviral pills cure the infection in most people within a few months.

Causes & Risk Factors

Hepatitis C spreads through contact with the blood of someone who has the virus. In the United States, sharing needles or other equipment used to inject drugs is the most common route, and even injecting once in the past counts as a risk. Medical exposures can also carry risk: a blood transfusion or organ transplant before July 1992 (when routine screening of the blood supply began), clotting factor received before 1987, long-term kidney dialysis, and needlestick injuries in health care work. Other routes include tattoos or piercings done with unsterile equipment, time in prison, and being born to a mother with hepatitis C. Sexual transmission is possible but uncommon; the risk is higher for men who have sex with men, people with HIV and people with several partners. Sharing razors, toothbrushes or nail clippers can also pass the virus. It does not spread through hugging, coughing, sharing utensils, food or water, or breast milk.

How It's Diagnosed

Testing usually happens in two steps from a single blood draw. The first is an antibody test, which shows whether the body has ever met the virus. A positive antibody test does not by itself mean a current infection: it can also reflect an infection that cleared on its own or was cured, and antibodies typically remain for life. So a positive result is followed by an HCV RNA test (also called a viral load test), which detects the virus's genetic material (RNA) in the blood. A detectable RNA result means the infection is active. US guidelines recommend a one-time hepatitis C test for all adults, testing during every pregnancy, and repeat testing for people with ongoing risk, such as current injection drug use. Once the infection is confirmed, the next question is how much the liver has been affected. Blood tests of liver function and blood counts can be combined into a score (such as FIB-4) that estimates scarring. Elastography, an ultrasound-based scan that measures liver stiffness (one common version is called FibroScan), or imaging may also be used. A liver biopsy is rarely needed. Before treatment, people are also tested for HIV and hepatitis B, because these infections change how treatment is planned and monitored.

Treatment Options

Treatment is recommended for nearly everyone with chronic hepatitis C. It uses direct-acting antivirals, pills that block the proteins the virus needs to copy itself. These medicines cure more than 95% of people, usually in 8 to 12 weeks, and are generally well tolerated. Cure means the virus is gone from the blood for good, and it greatly lowers the chance of liver failure, liver cancer and liver-related death. For most adults who have not been treated before and do not have cirrhosis, two combination pills cover every strain (genotype) of the virus. Glecaprevir and pibrentasvir (Mavyret) is taken as three tablets once a day with food for 8 weeks. Sofosbuvir and velpatasvir (Epclusa) is one tablet once a day for 12 weeks. Both are approved for children age 3 and older as well. People with cirrhosis, previous treatment, pregnancy, liver cancer or a liver transplant need a plan tailored by a specialist. In cirrhosis that has started causing complications (decompensated cirrhosis), for example, Mavyret is not used, and Epclusa may be combined with ribavirin, an older antiviral medicine. Two checks matter before starting. Everyone is tested for current or past hepatitis B, because hepatitis B can flare, sometimes severely, during or after hepatitis C treatment; people who carry it are monitored or treated for it. And the prescriber reviews every medicine, over-the-counter product and supplement, because some interact with these antivirals. People taking diabetes medicines or the blood thinner warfarin may need closer monitoring, since clearing the virus can lower blood sugar or change warfarin's effect. The medicines are expensive, but most government and private insurance plans provide some coverage, and assistance programs exist for people who need help paying. Taking every dose for the full course gives the best chance of cure.

What to Expect

For most people, treatment is a short and fairly uneventful stretch: one pill routine for two to three months, with little or no lab monitoring along the way for those without cirrhosis. Cure is confirmed with an HCV RNA test 12 weeks or more after the last dose. An undetectable result at that point means the infection has been cured. What comes after cure depends on how much damage was already done. People without cirrhosis usually need no further liver-specific follow-up. People with cirrhosis still need ongoing care, because the scarring does not disappear immediately and the risk of liver cancer remains: guidelines recommend a liver ultrasound every 6 months, along with monitoring for other complications of cirrhosis. Liver health often improves after cure, and some scarring can lessen over time. Cure does not give immunity. A person can be infected again, and because the antibody test stays positive after the first infection, an HCV RNA test is used to check for reinfection. People with ongoing risk are advised to retest at least yearly. Limiting alcohol, which adds its own damage, and getting vaccinated against hepatitis A and B help protect the liver. Until cure, the virus can be passed to others, so people with active infection should not share razors, toothbrushes or injecting equipment. People who have had hepatitis C are generally not eligible to donate blood, even after cure.

When to Seek Help

After a possible exposure, such as a needlestick or shared injecting equipment, see a clinician soon so the right timing of testing can be planned. Ask for a hepatitis C test if you have never had one as an adult, if you are pregnant, or if you have an ongoing risk. If you have been diagnosed but not treated, or treatment did not cure the infection, arrange a visit to discuss treatment rather than waiting for symptoms. Contact your care team promptly if you notice yellowing of the skin or eyes, a swelling belly, new swelling of the legs or ankles, or new confusion or trouble thinking, since these can be signs of advancing liver disease. For people with cirrhosis, vomiting blood (or material that looks like coffee grounds), black tarry stools, or severe confusion or drowsiness need emergency care right away: call 911 or go to an emergency room.

Questions to Ask Your Doctor

  1. 1.How much scarring does my liver have, and does that change which treatment or follow-up I need?
  2. 2.Which treatment do you recommend for me, how long will it last, and how will we confirm I am cured?
  3. 3.Do any of my current medicines or supplements need to change before I start?
  4. 4.What does my hepatitis B test show, and does it affect my plan?
  5. 5.After cure, what follow-up do I need, and how can I avoid getting infected again?

Last reviewed • Oct 2026

Educational content, not medical advice.